UniProt ID | TOP3A_HUMAN | |
---|---|---|
UniProt AC | Q13472 | |
Protein Name | DNA topoisomerase 3-alpha | |
Gene Name | TOP3A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1001 | |
Subcellular Localization | ||
Protein Description | Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(5'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 3'-OH DNA strand. The free DNA strand then undergoes passage around the unbroken strand thus removing DNA supercoils. Finally, in the religation step, the DNA 3'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone. Essential component of the RMI complex, a complex that plays an important role in the processing of homologous recombination intermediates to limit DNA crossover formation in cells. Has DNA decatenation activity.. | |
Protein Sequence | MIFPVARYALRWLRRPEDRAFSRAAMEMALRGVRKVLCVAEKNDAAKGIADLLSNGRMRRREGLSKFNKIYEFDYHLYGQNVTMVMTSVSGHLLAHDFQMQFRKWQSCNPLVLFEAEIEKYCPENFVDIKKTLERETRQCQALVIWTDCDREGENIGFEIIHVCKAVKPNLQVLRARFSEITPHAVRTACENLTEPDQRVSDAVDVRQELDLRIGAAFTRFQTLRLQRIFPEVLAEQLISYGSCQFPTLGFVVERFKAIQAFVPEIFHRIKVTHDHKDGIVEFNWKRHRLFNHTACLVLYQLCVEDPMATVVEVRSKPKSKWRPQALDTVELEKLASRKLRINAKETMRIAEKLYTQGYISYPRTETNIFPRDLNLTVLVEQQTPDPRWGAFAQSILERGGPTPRNGNKSDQAHPPIHPTKYTNNLQGDEQRLYEFIVRHFLACCSQDAQGQETTVEIDIAQERFVAHGLMILARNYLDVYPYDHWSDKILPVYEQGSHFQPSTVEMVDGETSPPKLLTEADLIALMEKHGIGTDATHAEHIETIKARMYVGLTPDKRFLPGHLGMGLVEGYDSMGYEMSKPDLRAELEADLKLICDGKKDKFVVLRQQVQKYKQVFIEAVAKAKKLDEALAQYFGNGTELAQQEDIYPAMPEPIRKCPQCNKDMVLKTKKNGGFYLSCMGFPECRSAVWLPDSVLEASRDSSVCPVCQPHPVYRLKLKFKRGSLPPTMPLEFVCCIGGCDDTLREILDLRFSGGPPRASQPSGRLQANQSLNRMDNSQHPQPADSRQTGSSKALAQTLPPPTAAGESNSVTCNCGQEAVLLTVRKEGPNRGRQFFKCNGGSCNFFLWADSPNPGAGGPPALAYRPLGASLGCPPGPGIHLGGFGNPGDGSGSGTSCLCSQPSVTRTVQKDGPNKGRQFHTCAKPREQQCGFFQWVDENTAPGTSGAPSWTGDRGRTLESEARSKRPRASSSDMGSTAKKPRKCSLCHQPGHTRPFCPQNR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
22 | Phosphorylation | RPEDRAFSRAAMEMA CHHHHHHHHHHHHHH | 21.74 | - | |
35 | Ubiquitination | MALRGVRKVLCVAEK HHHHHHCCEEEEECC | 36.83 | - | |
42 | Ubiquitination | KVLCVAEKNDAAKGI CEEEEECCCHHHHHH | 50.84 | - | |
47 | Ubiquitination | AEKNDAAKGIADLLS ECCCHHHHHHHHHHH | 53.20 | - | |
54 | Phosphorylation | KGIADLLSNGRMRRR HHHHHHHHCCHHHHH | 44.53 | 18669648 | |
66 | Ubiquitination | RRREGLSKFNKIYEF HHHHHHHHHHHHEEE | 58.98 | - | |
73 | Ubiquitination | KFNKIYEFDYHLYGQ HHHHHEEEEEEECCC | 6.75 | - | |
130 | Ubiquitination | PENFVDIKKTLERET CCCCCCHHHHHHHHH | 34.93 | - | |
162 | Ubiquitination | NIGFEIIHVCKAVKP CCCHHHHHHHHHCCC | 25.28 | - | |
168 | Ubiquitination | IHVCKAVKPNLQVLR HHHHHHCCCCHHHHH | 32.80 | - | |
226 | Ubiquitination | TRFQTLRLQRIFPEV HHHHHHHHHHHCHHH | 4.51 | - | |
232 (in isoform 2) | Ubiquitination | - | 39.14 | 21890473 | |
239 | Ubiquitination | EVLAEQLISYGSCQF HHHHHHHHHCCCCCC | 2.73 | - | |
250 | Ubiquitination | SCQFPTLGFVVERFK CCCCCCHHHHHHHHH | 18.77 | - | |
257 | Ubiquitination | GFVVERFKAIQAFVP HHHHHHHHHHHHHHH | 51.29 | 21890473 | |
257 (in isoform 1) | Ubiquitination | - | 51.29 | 21890473 | |
257 | Ubiquitination | GFVVERFKAIQAFVP HHHHHHHHHHHHHHH | 51.29 | 21890473 | |
258 | Ubiquitination | FVVERFKAIQAFVPE HHHHHHHHHHHHHHH | 9.09 | - | |
321 | Acetylation | VRSKPKSKWRPQALD EECCCCCCCCCCCCC | 54.04 | 25953088 | |
321 | Ubiquitination | VRSKPKSKWRPQALD EECCCCCCCCCCCCC | 54.04 | - | |
326 | Ubiquitination | KSKWRPQALDTVELE CCCCCCCCCCHHHHH | 15.30 | - | |
334 | Ubiquitination | LDTVELEKLASRKLR CCHHHHHHHHHCCCC | 63.08 | - | |
345 | Ubiquitination | RKLRINAKETMRIAE CCCCCCHHHHHHHHH | 49.59 | - | |
353 | Ubiquitination | ETMRIAEKLYTQGYI HHHHHHHHHHHCCCC | 37.46 | - | |
355 | Phosphorylation | MRIAEKLYTQGYISY HHHHHHHHHCCCCCC | 14.21 | 23663014 | |
356 | Phosphorylation | RIAEKLYTQGYISYP HHHHHHHHCCCCCCC | 26.42 | 23663014 | |
359 | Phosphorylation | EKLYTQGYISYPRTE HHHHHCCCCCCCCCC | 4.11 | 23663014 | |
361 | Phosphorylation | LYTQGYISYPRTETN HHHCCCCCCCCCCCC | 22.17 | 23663014 | |
362 | Phosphorylation | YTQGYISYPRTETNI HHCCCCCCCCCCCCC | 6.28 | 23663014 | |
421 | Ubiquitination | HPPIHPTKYTNNLQG CCCCCCCCCCCCCCC | 55.30 | - | |
451 | Ubiquitination | CCSQDAQGQETTVEI HHCCCCCCCEEEEEE | 29.07 | - | |
462 | Ubiquitination | TVEIDIAQERFVAHG EEEEEHHHHHHHHHH | 42.61 | - | |
498 | Phosphorylation | LPVYEQGSHFQPSTV ECCCCCCCCCCCCCE | 22.33 | 29116813 | |
503 | Phosphorylation | QGSHFQPSTVEMVDG CCCCCCCCCEEEECC | 34.01 | 29116813 | |
504 | Phosphorylation | GSHFQPSTVEMVDGE CCCCCCCCEEEECCC | 27.45 | 29116813 | |
507 | Ubiquitination | FQPSTVEMVDGETSP CCCCCEEEECCCCCC | 2.64 | - | |
513 | Phosphorylation | EMVDGETSPPKLLTE EEECCCCCCCCCCCH | 34.60 | 29116813 | |
529 | Ubiquitination | DLIALMEKHGIGTDA HHHHHHHHCCCCCCC | 32.92 | - | |
546 | Ubiquitination | AEHIETIKARMYVGL HHHHHHHHHHHCCCC | 37.04 | - | |
554 | Phosphorylation | ARMYVGLTPDKRFLP HHHCCCCCCCCCCCC | 24.42 | - | |
557 | Ubiquitination | YVGLTPDKRFLPGHL CCCCCCCCCCCCCCC | 46.37 | - | |
576 | Ubiquitination | VEGYDSMGYEMSKPD CCCCHHCCCCCCCCH | 21.14 | - | |
602 | Ubiquitination | ICDGKKDKFVVLRQQ EECCCCCEEEEEHHH | 49.27 | - | |
668 | Acetylation | CNKDMVLKTKKNGGF CCCCEEEEEEECCCE | 47.06 | 19826825 | |
669 | Phosphorylation | NKDMVLKTKKNGGFY CCCEEEEEEECCCEE | 42.99 | 20166139 | |
670 | Acetylation | KDMVLKTKKNGGFYL CCEEEEEEECCCEEE | 42.53 | 19826833 | |
671 | Ubiquitination | DMVLKTKKNGGFYLS CEEEEEEECCCEEEE | 67.09 | - | |
694 | Phosphorylation | SAVWLPDSVLEASRD CCEECCHHHHHHCCC | 27.02 | - | |
703 | Phosphorylation | LEASRDSSVCPVCQP HHHCCCCCCCCCCCC | 31.84 | - | |
760 | Phosphorylation | SGGPPRASQPSGRLQ CCCCCCCCCCCCCCC | 43.85 | 26714015 | |
771 | Phosphorylation | GRLQANQSLNRMDNS CCCCCCHHHHCCCCC | 27.67 | 25159151 | |
778 | Phosphorylation | SLNRMDNSQHPQPAD HHHCCCCCCCCCCCC | 26.12 | - | |
964 | Phosphorylation | TLESEARSKRPRASS CHHHHHHHCCCCCCC | 39.81 | - | |
970 | Phosphorylation | RSKRPRASSSDMGST HHCCCCCCCCCCCCC | 31.49 | 28176443 | |
971 | Phosphorylation | SKRPRASSSDMGSTA HCCCCCCCCCCCCCC | 29.40 | 28985074 | |
972 | Phosphorylation | KRPRASSSDMGSTAK CCCCCCCCCCCCCCC | 29.17 | 28176443 | |
976 | Phosphorylation | ASSSDMGSTAKKPRK CCCCCCCCCCCCCCC | 20.67 | 29083192 | |
977 | Phosphorylation | SSSDMGSTAKKPRKC CCCCCCCCCCCCCCC | 36.45 | 29083192 | |
985 | Phosphorylation | AKKPRKCSLCHQPGH CCCCCCCCCCCCCCC | 36.75 | 28152594 | |
993 | Phosphorylation | LCHQPGHTRPFCPQN CCCCCCCCCCCCCCC | 46.05 | 28152594 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TOP3A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TOP3A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TOP3A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BLM_HUMAN | BLM | physical | 11470874 | |
BLM_HUMAN | BLM | physical | 11406610 | |
RFA1_HUMAN | RPA1 | physical | 12724401 | |
FANCA_HUMAN | FANCA | physical | 12724401 | |
BLM_HUMAN | BLM | physical | 12724401 | |
TERF2_HUMAN | TERF2 | physical | 18418389 | |
RMI1_HUMAN | RMI1 | physical | 24509834 | |
CHK1_HUMAN | CHEK1 | genetic | 27453043 | |
BRCA2_HUMAN | BRCA2 | genetic | 27453043 | |
WEE1_HUMAN | WEE1 | genetic | 27453043 | |
PALB2_HUMAN | PALB2 | genetic | 27453043 | |
RAD17_HUMAN | RAD17 | genetic | 27453043 | |
L2GL1_HUMAN | LLGL1 | genetic | 27453043 | |
MSH2_HUMAN | MSH2 | genetic | 27453043 | |
NF1_HUMAN | NF1 | genetic | 27453043 | |
RS11_HUMAN | RPS11 | genetic | 27453043 | |
CDC73_HUMAN | CDC73 | genetic | 27453043 | |
CDC6_HUMAN | CDC6 | genetic | 27453043 | |
M3K4_HUMAN | MAP3K4 | genetic | 27453043 | |
TITIN_HUMAN | TTN | genetic | 27453043 | |
FUMH_HUMAN | FH | genetic | 27453043 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-54 AND SER-771, AND MASSSPECTROMETRY. |